A detailed history of Everett Harris & CO transactions in Amgen Inc stock. As of the latest transaction made, Everett Harris & CO holds 23,688 shares of AMGN stock, worth $7.58 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
23,688
Previous 22,379 5.85%
Holding current value
$7.58 Million
Previous $6.99 Million 9.15%
% of portfolio
0.1%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$309.38 - $337.38 $404,978 - $441,630
1,309 Added 5.85%
23,688 $7.63 Million
Q2 2024

Aug 01, 2024

SELL
$262.75 - $319.31 $694,711 - $844,255
-2,644 Reduced 10.57%
22,379 $6.99 Million
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $665,184 - $802,961
2,474 Added 10.97%
25,023 $7.11 Million
Q4 2023

Jan 18, 2024

BUY
$255.7 - $288.46 $166,205 - $187,499
650 Added 2.97%
22,549 $6.49 Million
Q3 2023

Oct 23, 2023

BUY
$218.65 - $271.46 $19,241 - $23,888
88 Added 0.4%
21,899 $5.89 Million
Q2 2023

Jul 26, 2023

BUY
$214.27 - $253.37 $49,282 - $58,275
230 Added 1.07%
21,811 $4.84 Million
Q1 2023

Apr 24, 2023

BUY
$225.79 - $275.2 $43,125 - $52,563
191 Added 0.89%
21,581 $5.22 Million
Q4 2022

Jan 20, 2023

BUY
$229.03 - $291.01 $151,846 - $192,939
663 Added 3.2%
21,390 $0
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $5,611 - $6,328
25 Added 0.12%
20,727 $4.67 Million
Q2 2022

Jul 22, 2022

SELL
$230.71 - $256.74 $230,940 - $256,996
-1,001 Reduced 4.61%
20,702 $5.04 Million
Q1 2022

Apr 22, 2022

SELL
$219.27 - $242.57 $164,891 - $182,412
-752 Reduced 3.35%
21,703 $5.25 Million
Q4 2021

Feb 02, 2022

BUY
$198.88 - $227.6 $88,302 - $101,054
444 Added 2.02%
22,455 $5.05 Million
Q3 2021

Nov 03, 2021

BUY
$212.27 - $248.7 $81,936 - $95,998
386 Added 1.78%
22,011 $4.68 Million
Q2 2021

Jul 29, 2021

BUY
$233.58 - $259.14 $72,409 - $80,333
310 Added 1.45%
21,625 $5.27 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $337,081 - $392,813
1,519 Added 7.67%
21,315 $5.3 Million
Q4 2020

Feb 04, 2021

SELL
$216.38 - $257.67 $38,299 - $45,607
-177 Reduced 0.89%
19,796 $4.55 Million
Q3 2020

Nov 03, 2020

SELL
$234.65 - $260.95 $55,846 - $62,106
-238 Reduced 1.18%
19,973 $5.08 Million
Q2 2020

Jul 29, 2020

BUY
$197.81 - $242.74 $9,099 - $11,166
46 Added 0.23%
20,211 $4.77 Million
Q1 2020

Apr 29, 2020

BUY
$182.24 - $241.7 $326,756 - $433,368
1,793 Added 9.76%
20,165 $4.09 Million
Q4 2019

Jan 27, 2020

BUY
$189.21 - $243.2 $28,570 - $36,723
151 Added 0.83%
18,372 $4.43 Million
Q3 2019

Nov 06, 2019

SELL
$174.11 - $208.62 $17,411 - $20,862
-100 Reduced 0.55%
18,221 $3.53 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $180 - $203
1 Added 0.01%
18,321 $3.48 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $35,680 - $41,650
200 Added 1.1%
18,320 $3.57 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $37,243 - $41,986
201 Added 1.12%
18,120 $3.76 Million
Q2 2018

Jul 27, 2018

SELL
$166.05 - $186.51 $41,512 - $46,627
-250 Reduced 1.38%
17,919 $3.31 Million
Q1 2018

Apr 20, 2018

BUY
$169.43 - $198.0 $506,595 - $592,020
2,990 Added 19.7%
18,169 $3.1 Million
Q4 2017

Feb 01, 2018

BUY
$168.79 - $188.59 $25,487 - $28,477
151 Added 1.0%
15,179 $2.64 Million
Q3 2017

Oct 11, 2017

BUY
$167.29 - $191.0 $2.51 Million - $2.87 Million
15,028
15,028 $2.8 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.